Back to search

Article

Prevention of myopia shift and myopia onset using 0.01% atropine in premyopic children - A Prospective, Randomized, Double-masked, Crossover Trial

2022-12-01

Abstract excerpt

To evaluate the efficacy of 0.01% atropine eye drops in preventing myopia shift and myopia onset in premyopic children. A prospective, randomized, double-masked, placebo-controlled, crossover trial was conducted over 13 months. Sixty premyopic children aged 6–12 years with cycloplegic spherical equivalent refraction (SER) > -0.75 D and ≤ + 0.50 D in both eyes were assigned in a 1:1 ratio to receive one drop of 0.0...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c740c468-8e3d-5b03-bc88-1289fc5dbac1
DOI
10.21203/rs.3.rs-2314578/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Prevention of myopia shift and myopia onset using 0.01% atropine in premyopic children - A Prospective, Randomized, Double-masked, Crossover TrialDOI 10.21203/rs.3.rs-2314578/v1
Select a neighboring publication to make it the new centre.